Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system. - Wikidata - wikimedia - TriplyDB

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.

http://www.wikidata.org/entity/Q35900223

about

Comparison of linezolid activities under aerobic and anaerobic conditions against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.Effect of aerobic and anaerobic environments on antistaphylococcal activities of five fluoroquinolones In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kinetics.Fluoroquinolone resistance in Bacteroides fragilis following sparfloxacin exposure A new approach to in vitro comparisons of antibiotics in dynamic models: equivalent area under the curve/MIC breakpoints and equiefficient doses of trovafloxacin and ciprofloxacin against bacteria of similar susceptibilities Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.Comparative pharmacodynamics of three newer fluoroquinolones versus six strains of staphylococci in an in vitro model under aerobic and anaerobic conditions.Synergistic activity of colistin and ceftazidime against multiantibiotic-resistant Pseudomonas aeruginosa in an in vitro pharmacodynamic model.Twenty-four-hour area under the concentration-time curve/MIC ratio as a generic predictor of fluoroquinolone antimicrobial effect by using three strains of Pseudomonas aeruginosa and an in vitro pharmacodynamic model.Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.Pharmacodynamics of moxifloxacin against anaerobes studied in an in vitro pharmacokinetic model.Colistin methanesulfonate against multidrug-resistant Acinetobacter baumannii in an in vitro pharmacodynamic model.

P2860

Q34720017-56DF82C3-458E-41FA-9496-396911FBA938 Q35111853-B0CB04A5-6127-4D01-8DDE-B260B3DDA57B Q36018672-57F6939D-C1DB-481F-B59C-0FB24262267A Q39471750-6A937BC1-C4EA-4FEE-89DE-074ED9B82771 Q39559370-F7B3AA22-11EF-478E-B17D-9CED2FEA72F0 Q39650985-A336E255-975B-43FA-9C29-9BD50248B568 Q39651777-E2FABDC7-77BE-4F77-861E-96C88FEF33D3 Q39731815-7E923994-EE3E-43B2-A262-46530966AA0E Q39781591-AA31F80C-DD58-4224-ACB4-34E51F5ECA40 Q41005606-09CEB761-9D5D-4CCD-B8E8-A2F24C9F1715 Q41832949-6F970F79-68DA-41AB-8671-2F952B88BF88 Q42014130-566740B1-B68A-4475-B8EE-8B10CAB68477

P2860

Evaluation of activity of temafloxacin against Bacteroides fragilis by an in vitro pharmacodynamic system.

http://www.wikidata.org/entity/Q35900223

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@ast

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@en

type

label

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@ast

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@en

prefLabel

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@ast

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@en

P1433

Q35900223-E831F18A-E9BB-4DA0-A861-4F4CF938445A

P1476

Q35900223-B64DE9F1-DC06-4342-8D87-C591836E4747

P2093

Q35900223-13A33BA0-0942-4A8D-8A24-EFB05E5339C9

Q35900223-5431B50B-01E1-489E-82AD-B6C5EB23E129

Q35900223-8D5EF0CE-E3A8-432F-89EB-29AF86F398BE

Q35900223-A9335F43-C72D-4B2E-B462-1F6AA31A283F

Q35900223-B5B4FA0B-8EA2-4A8E-82CB-DFE918B4D020

Q35900223-BC2D3E5E-2137-4892-BB45-46F3D5FFE9B5

P2860

Q35900223-0D2E39F9-B8AF-4796-AB07-5DE5C23CC239

Q35900223-2D9B23B8-90B6-430C-8A8C-3D9545311492

Q35900223-8A2A99FF-3209-467B-A5B7-DA5458D2C21F

Q35900223-AB483EC1-0B1D-400A-A7F9-C21AE5544BE8

Q35900223-C5DF0738-40A0-4A6B-B8A4-8049284051A3

Q35900223-DC430E81-7D99-499A-A984-F3B2E4C8446F

Q35900223-F13BCC3D-3E66-460D-94D4-67E9183C8F64

Q35900223-F3485F33-94E7-4EAF-AD3D-D580AE1A6115

Q35900223-F3A2EA18-1B38-48DC-BD8C-23491C8EF6FC

P304

Q35900223-D152FD8F-8E5E-4614-A6C1-76C4D56FC9E5

P31

Q35900223-B38E33E7-48E4-4ED0-86EA-3E5ED7AD696C

P356

Q35900223-9FE24972-EDA2-4146-847B-2AEBC23C3980

P407

Q35900223-C5E2A952-B3D5-42C3-8B09-97F5D33C21D0

P433

Q35900223-C5034B37-DBE6-427C-AB1E-5CB5A09A4870

P478

Q35900223-150B234E-7C41-4CD3-8490-463B000FB98F

P577

Q35900223-12B24AA9-2733-4BB5-B50E-C3EE95F6185B

P5875

Q35900223-175892E6-2EB0-4C61-ABF1-6651C6116D28

P698

Q35900223-9FA7D033-EA87-4447-9F06-0275DF28FACF

P932

Q35900223-8CD59C89-4EBD-4089-BAD3-29E66D831BA6

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Evaluation of activity of tema ...... vitro pharmacodynamic system.

@en

P2093

Krinke AJ

http://www.w3.org/2001/XMLSchema#string

Moody JA

http://www.w3.org/2001/XMLSchema#string

Rotschafer JC

http://www.w3.org/2001/XMLSchema#string

Vance-Bryan K

http://www.w3.org/2001/XMLSchema#string

Walker KJ

http://www.w3.org/2001/XMLSchema#string

Zabinski RA

http://www.w3.org/2001/XMLSchema#string

P2860

Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.

Assessment of effects of protein binding on daptomycin and vancomycin killing of Staphylococcus aureus by using an in vitro pharmacodynamic model

Pharmacodynamics of a fluoroquinolone antimicrobial agent in a neutropenic rat model of Pseudomonas sepsis

Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria

Pharmacodynamics of once-daily amikacin in various combinations with cefepime, aztreonam, and ceftazidime against Pseudomonas aeruginosa in an in vitro infection model.

The in-vitro activity, pharmacokinetics and tissue penetration of temafloxacin.

Comparative study with enoxacin and netilmicin in a pharmacodynamic model to determine importance of ratio of antibiotic peak concentration to MIC for bactericidal activity and emergence of resistance.

Combination therapy with ciprofloxacin plus azlocillin against Pseudomonas aeruginosa: effect of simultaneous versus staggered administration in an in vitro model of infection.

Effect of human serum on the bactericidal activity of daptomycin and vancomycin against staphylococcal and enterococcal isolates as determined by time-kill kinetic studies.

P304

2454-2458

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.37.11.2454

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

37

http://www.w3.org/2001/XMLSchema#string

P577

1993-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14912927

http://www.w3.org/2001/XMLSchema#string

P698

8285633

http://www.w3.org/2001/XMLSchema#string

P932

192408

http://www.w3.org/2001/XMLSchema#string